XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock and Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Common Stock and Stockholders'Equity  
Summary of stock option activity under the Plan

Activity under the Plans is as follows (in thousands, except share and per share amounts and years):

    

    

Weighted-

    

 

Weighted-

Average

 

Number of

Average

Remaining

Aggregate

 

Shares

Exercise

Contractual

Intrinsic

 

Outstanding

Price

Life in Years

Value

 

Balance at December 31, 2020

5,826,685

$

17.19

 

5.31

$

1,064,944

Stock option grants

3,688

$

107.06

 

N/A

Stock options exercised

(1,237,399)

$

9.62

 

N/A

$

(212,993)

Stock options forfeited

(44,031)

$

14.47

 

N/A

Balance at March 31, 2021

4,548,943

$

19.41

 

5.69

$

738,498

Vested or expected to vest at March 31, 2021

4,548,943

$

19.41

 

5.69

$

738,498

Exercisable at March 31, 2021

3,700,190

$

16.88

 

5.33

$

610,040

Assumptions used for estimate of fair value of options

Quarter Ended March 31,

    

2021

    

2020

    

Volatility

 

57.02% - 57.49%

46.1% – 47.9%

Expected term (in years)

 

4.1

4.3

Risk-free interest rate

 

0.31% - 0.51%

0.87% - 1.64%

Dividend yield

 

0

0

Weighted-average fair value of underlying stock options

$

$107.06

$

42.06

Schedule of activity under the RSUs

Activity under the RSUs is as follows:

Weighted-Average

Grant Date

    

RSUs

    

Fair Value Per RSU

Balance at December 31, 2020

3,550,595

$

162.11

Granted

 

402,210

$

218.88

Vested and issued

(708,798)

$

102.94

Forfeited

(115,243)

$

184.40

Balance at March 31, 2021

 

3,128,764

$

181.99

Vested and unissued at March 31, 2021

13,755

$

50.90

Non-vested at March 31, 2021

3,115,009

$

182.57

Schedule of activity under the PSUs

Activity under the PSUs is as follows:

Weighted-Average

Grant Date

    

Shares

    

Fair Value Per PSU

Balance at December 31, 2020

429,319

$

76.60

Granted

 

516,031

$

131.67

Vested and issued

(268,201)

$

74.33

Balance at March 31, 2021

 

677,149

$

119.47

Vested and unissued at March 31, 2021

0

$

0

Non-vested at March 31, 2021

677,149

$

119.47

Components of operating expense charged for compensation cost expense

Total compensation costs for stock-based awards were recorded as follows (in thousands):

Quarter Ended

March 31,

    

2021

    

2020

    

Cost of revenue (exclusive of depreciation and amortization, which is shown separately)

$

2,362

$

0

Advertising and marketing

5,082

1,259

Sales

 

21,167

 

2,919

Technology and development

 

26,726

 

2,104

General and administrative

 

30,963

 

12,033

Total stock-based compensation expense (1)

$

86,300

$

18,315